{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:27:27Z","timestamp":1786998447152,"version":"build-2736575974"},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,21]],"date-time":"2025-03-21T00:00:00Z","timestamp":1742515200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372166"],"award-info":[{"award-number":["82372166"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82302430"],"award-info":[{"award-number":["82302430"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.yexcr.2025.114519","type":"journal-article","created":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T17:10:08Z","timestamp":1742663408000},"page":"114519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["CMTM4 promotes PD-L1-mediated macrophage apoptosis by enhancing STAT2 phosphorylation in sepsis"],"prefix":"10.1016","volume":"447","author":[{"given":"Feng","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhujun","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2025.114519_bib1","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2025.114519_bib2","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1097\/CCM.0000000000005337","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021","volume":"49","author":"Evans","year":"2021","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.yexcr.2025.114519_bib3","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1001\/jama.2016.0288","article-title":"Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3)","volume":"315","author":"Seymour","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2025.114519_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/s41419-019-2015-1","article-title":"Pathological alteration and therapeutic implications of sepsis-induced immune cell apoptosis","volume":"10","author":"Cao","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.yexcr.2025.114519_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver - guardian, modifier and target of sepsis","volume":"14","author":"Strnad","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.yexcr.2025.114519_bib6","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/0885066613488739","article-title":"The association of serum bilirubin levels on the outcomes of severe sepsis","volume":"30","author":"Patel","year":"2015","journal-title":"J. Intensive Care Med."},{"key":"10.1016\/j.yexcr.2025.114519_bib7","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/nri3552","article-title":"Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy","volume":"13","author":"Hotchkiss","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2025.114519_bib8","first-page":"56","article-title":"Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options","volume":"9","author":"Liu","year":"2022","journal-title":"Mil Med Res"},{"key":"10.1016\/j.yexcr.2025.114519_bib9","article-title":"Programmed cell death in sepsis associated acute kidney injury","volume":"9","author":"Wu","year":"2022","journal-title":"Front. Med."},{"key":"10.1016\/j.yexcr.2025.114519_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/BS9.0000000000000117","article-title":"Disulfiram, an aldehyde dehydrogenase inhibitor, works as a potent drug against sepsis and cancer via NETosis, pyroptosis, apoptosis, ferroptosis, and cuproptosis","volume":"4","author":"Nie","year":"2022","journal-title":"Blood Sci"},{"key":"10.1016\/j.yexcr.2025.114519_bib11","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/CVI.00752-12","article-title":"Association of \u03b3\u03b4 T cells with disease severity and mortality in septic patients","volume":"20","author":"Andreu-Ballester","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.yexcr.2025.114519_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/imr.12499","article-title":"The immune system's role in sepsis progression, resolution, and long-term outcome","volume":"274","author":"Delano","year":"2016","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.yexcr.2025.114519_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jare.2022.04.010","article-title":"EGFR promotes the apoptosis of CD4(+) T lymphocytes through TBK1\/Glut1 induced Warburg effect in sepsis","volume":"44","author":"Huang","year":"2023","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.yexcr.2025.114519_bib14","article-title":"Early immune system alterations in patients with septic shock","volume":"14","author":"Tang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114519_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1042\/bj3570127","article-title":"Molecular cloning and characterization of chemokine-like factor 1 (CKLF1), a novel human cytokine with unique structure and potential chemotactic activity","volume":"357","author":"Han","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2025.114519_bib16","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.7150\/ijbs.33733","article-title":"Research advances in CKLF-like MARVEL transmembrane domain-containing family in non-small cell lung cancer","volume":"15","author":"Wu","year":"2019","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.yexcr.2025.114519_bib17","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0968-0004(02)02229-6","article-title":"MARVEL: a conserved domain involved in membrane apposition events","volume":"27","author":"S\u00e1nchez-Pulido","year":"2002","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.yexcr.2025.114519_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s10456-018-9638-1","article-title":"CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions","volume":"22","author":"Chrifi","year":"2019","journal-title":"Angiogenesis"},{"key":"10.1016\/j.yexcr.2025.114519_bib19","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nature23669","article-title":"Identification of CMTM6 and CMTM4 as PD-L1 protein regulators","volume":"549","author":"Mezzadra","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2025.114519_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s10059-010-0038-7","article-title":"Identification and characterization of CMTM4, a novel gene with inhibitory effects on HeLa cell growth through Inducing G2\/M phase accumulation","volume":"29","author":"Plate","year":"2010","journal-title":"Mol. Cells"},{"key":"10.1016\/j.yexcr.2025.114519_bib21","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/abbs\/gmz084","article-title":"CMTM4 inhibits cell proliferation and migration via AKT, ERK1\/2, and STAT3 pathway in colorectal cancer","volume":"51","author":"Xue","year":"2019","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.yexcr.2025.114519_bib22","doi-asserted-by":"crossref","first-page":"13330","DOI":"10.1002\/jcb.28607","article-title":"An immunophenotyping of renal clear cell carcinoma with characteristics and a potential therapeutic target for patients insensitive to immune checkpoint blockade","volume":"120","author":"Zhao","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.yexcr.2025.114519_bib23","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.hbpd.2020.06.004","article-title":"Increased CMTM4 mRNA expression predicts a poor prognosis in patients with hepatocellular carcinoma","volume":"19","author":"Zhou","year":"2020","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.yexcr.2025.114519_bib24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2020.00057","article-title":"Transcriptomic features of T cell-barren tumors are conserved across diverse tumor types","volume":"11","author":"Routh","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.yexcr.2025.114519_bib25","first-page":"727","article-title":"PD-1\/PD-L1 pathway: current researches in cancer","volume":"10","author":"Han","year":"2020","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.yexcr.2025.114519_bib26","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1001\/jama.2011.1829","article-title":"Immunosuppression in patients who die of sepsis and multiple organ failure","volume":"306","author":"Boomer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.yexcr.2025.114519_bib27","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/cc9354","article-title":"PD-L1 blockade improves survival in experimental sepsis by inhibiting lymphocyte apoptosis and reversing monocyte dysfunction","volume":"14","author":"Zhang","year":"2010","journal-title":"Crit. Care"},{"key":"10.1016\/j.yexcr.2025.114519_bib28","doi-asserted-by":"crossref","first-page":"R85","DOI":"10.1186\/cc12711","article-title":"Blockade of the negative co-stimulatory molecules PD-1 and CTLA-4 improves survival in primary and secondary fungal sepsis","volume":"17","author":"Chang","year":"2013","journal-title":"Crit. Care"},{"key":"10.1016\/j.yexcr.2025.114519_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1189\/jlb.0110037","article-title":"Delayed administration of anti-PD-1 antibody reverses immune dysfunction and improves survival during sepsis","volume":"88","author":"Brahmamdam","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yexcr.2025.114519_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/361501","article-title":"PD-L1 blockade attenuated sepsis-induced liver injury in a mouse cecal ligation and puncture model","volume":"2013","author":"Zhu","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.yexcr.2025.114519_bib31","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1189\/jlb.4HI0616-255R","article-title":"Frontline Science: defects in immune function in patients with sepsis are associated with PD-1 or PD-L1 expression and can be restored by antibodies targeting PD-1 or PD-L1","volume":"100","author":"Patera","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.yexcr.2025.114519_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104727","article-title":"Panaxadiol inhibits programmed cell death-ligand 1 expression and tumour proliferation via hypoxia-inducible factor (HIF)-1\u03b1 and STAT3 in human colon cancer cells","volume":"155","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.yexcr.2025.114519_bib33","doi-asserted-by":"crossref","first-page":"22830","DOI":"10.18632\/aging.203575","article-title":"Inhibition of JAK2\/STAT3 signaling pathway by panaxadiol limits the progression of pancreatic cancer","volume":"13","author":"Fan","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.yexcr.2025.114519_bib34","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.4049\/jimmunol.166.12.7486","article-title":"Cooperative regulation of Mcl-1 by Janus kinase\/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils","volume":"166","author":"Epling-Burnette","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2025.114519_bib35","article-title":"The JAK\/STAT3 signaling pathway mediates inhibition of host cell apoptosis by Chlamydia psittaci infection","volume":"75","author":"Sun","year":"2017","journal-title":"Pathog Dis"},{"key":"10.1016\/j.yexcr.2025.114519_bib36","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/mc.23323","article-title":"CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma","volume":"60","author":"Li","year":"2021","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.yexcr.2025.114519_bib37","doi-asserted-by":"crossref","first-page":"ar116","DOI":"10.1091\/mbc.E22-05-0152","article-title":"MARVEL domain containing CMTM4 affects CXCR4 trafficking","volume":"33","author":"Bona","year":"2022","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.yexcr.2025.114519_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature23643","article-title":"CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity","volume":"549","author":"Burr","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2025.114519_bib39","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1126\/science.282.5396.2085","article-title":"Defective LPS signaling in C3H\/HeJ and C57BL\/10ScCr mice: mutations in Tlr4 gene","volume":"282","author":"Poltorak","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2025.114519_bib40","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1084\/jem.189.11.1777","article-title":"MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4","volume":"189","author":"Shimazu","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2025.114519_bib41","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nature07830","article-title":"The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex","volume":"458","author":"Park","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2025.114519_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.yexcr.2025.114519_bib43","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1038\/s41590-022-01325-9","article-title":"CMTM4 is a subunit of the IL-17 receptor and mediates autoimmune pathology","volume":"23","author":"Knizkova","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.yexcr.2025.114519_bib44","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.immuni.2012.03.013","article-title":"The JAK-STAT pathway at twenty","volume":"36","author":"Stark","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.yexcr.2025.114519_bib45","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nrm909","article-title":"Stats: transcriptional control and biological impact","volume":"3","author":"Levy","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114519_bib46","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1074\/jbc.M112.402529","article-title":"Identification of STAT2 serine 287 as a novel regulatory phosphorylation site in type I interferon-induced cellular responses","volume":"288","author":"Steen","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114519_bib47","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/383344a0","article-title":"Cooperation of Stat2 and p300\/CBP in signalling induced by interferon-alpha","volume":"383","author":"Bhattacharya","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2025.114519_bib48","doi-asserted-by":"crossref","first-page":"25343","DOI":"10.1074\/jbc.274.36.25343","article-title":"Stat protein transactivation domains recruit p300\/CBP through widely divergent sequences","volume":"274","author":"Paulson","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114519_bib49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncb747","article-title":"IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff","volume":"4","author":"Paulson","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.yexcr.2025.114519_bib50","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1242\/jcs.078253","article-title":"pp32, an INHAT component, is a transcription machinery recruiter for maximal induction of IFN-stimulated genes","volume":"124","author":"Kadota","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.yexcr.2025.114519_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007745","article-title":"STAT2 dependent Type I Interferon response promotes dysbiosis and luminal expansion of the enteric pathogen Salmonella Typhimurium","volume":"15","author":"Wilson","year":"2019","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.yexcr.2025.114519_bib52","doi-asserted-by":"crossref","first-page":"256","DOI":"10.33594\/000000370","article-title":"IFN-\u0392, but not IFN-\u03b1, is responsible for the pro-bacterial effect of type I interferon","volume":"55","author":"Shaabani","year":"2021","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.yexcr.2025.114519_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92220-0","article-title":"Secondary bacterial infection in COVID-19 patients is a stronger predictor for death compared to influenza patients","volume":"11","author":"Shafran","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.yexcr.2025.114519_bib54","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1126\/science.abc3545","article-title":"Type III interferons disrupt the lung epithelial barrier upon viral recognition","volume":"369","author":"Broggi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2025.114519_bib55","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1126\/science.abc2061","article-title":"Type I and III interferons disrupt lung epithelial repair during recovery from viral infection","volume":"369","author":"Major","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2025.114519_bib56","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2025.114519_bib57","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1038\/nri1900","article-title":"IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors","volume":"6","author":"Honda","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.yexcr.2025.114519_bib58","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1084\/jem.20101664","article-title":"Type I interferon: friend or foe?","volume":"207","author":"Trinchieri","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.yexcr.2025.114519_bib59","doi-asserted-by":"crossref","first-page":"20070","DOI":"10.1074\/jbc.272.32.20070","article-title":"Distinct STAT structure promotes interaction of STAT2 with the p48 subunit of the interferon-alpha-stimulated transcription factor ISGF3","volume":"272","author":"Martinez-Moczygemba","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114519_bib60","doi-asserted-by":"crossref","first-page":"20217","DOI":"10.1074\/jbc.M111.231068","article-title":"Chromatin dynamics of gene activation and repression in response to interferon alpha (IFN(alpha)) reveal new roles for phosphorylated and unphosphorylated forms of the transcription factor STAT2","volume":"286","author":"Testoni","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2025.114519_bib61","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2016.02.010","article-title":"The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses","volume":"29","author":"Blaszczyk","year":"2016","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.yexcr.2025.114519_bib62","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1042\/BJ20140644","article-title":"STAT2\/IRF9 directs a prolonged ISGF3-like transcriptional response and antiviral activity in the absence of STAT1","volume":"466","author":"Blaszczyk","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.yexcr.2025.114519_bib63","first-page":"495","article-title":"PD-1\/PD-L1 interaction regulates BCL2, KI67, BAX, and CASP3, altering proliferation, survival, and apoptosis in acute myeloid leukemia","volume":"22","author":"Soltani","year":"2023","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"10.1016\/j.yexcr.2025.114519_bib64","article-title":"Upregulated PD-L1 delays human neutrophil apoptosis and promotes lung injury in an experimental mouse model of sepsis","volume":"138","author":"Jia-Feng","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2025.114519_bib65","article-title":"B7-H3 augments the inflammatory response and is associated with human sepsis","volume":"185","author":"Guangbo","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.yexcr.2025.114519_bib66","article-title":"B7-H3 participates in the development of experimental pneumococcal meningitis by augmentation of the inflammatory response via a TLR2-dependent mechanism","volume":"189","author":"Xuqin","year":"2012","journal-title":"J. Immunol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725001156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482725001156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:23:46Z","timestamp":1762147426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482725001156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S0014482725001156"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114519","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CMTM4 promotes PD-L1-mediated macrophage apoptosis by enhancing STAT2 phosphorylation in sepsis","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2025.114519","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"114519"}}